Medication-Assisted Treatment - Prescription Drug and Opioid Addiction

This contract aims to enhance the accessibility of medications used in treating opioid use disorder, thereby increasing the availability of effective treatment and recovery options for affected individuals. The initiative focuses on reducing the misuse of prescription opioids, illicit opioid consumption, and overdose incidents. Administered by the Substance Abuse and Mental Health Services Administration under the Department of Health and Human Services, the program seeks to address the ongoing opioid crisis through improved medication-assisted treatment strategies. Although specific geographic locations and set-aside criteria are not detailed, the program is positioned to support broad efforts to combat opioid addiction nationwide. The contract forecast was posted on March 20, 2026, and inquiries can be directed to the designated point of contact, Fred Bamfo, via email or telephone. This opportunity underscores the federal commitment to expanding treatment options and mitigating the public health impact of the opioid epidemic.